Revenue distribution by sectors:

1. Traditional Chinese Medicine: approx. 70%
2. Health products: approx. 20%
3. Other services: approx. 10%

TOP 3 markets and their percentage shares:

1. China: approx. 60%
2. Southeast Asia: approx. 25%
3. Europe: approx. 15%

Tibet Cheezheng Tibetan Medicine Co., Ltd. generates the majority of its revenue from traditional Chinese medicine, with the domestic market of China accounting for the largest share. In recent years, the company has expanded its market presence in Southeast Asia and Europe, which is reflected in the revenue shares of these regions. The diversification into health products and services also contributes to the revenue structure.

Production Location: Tibet, China

Tibet Cheezheng Tibetan Medicine Co., Ltd. mainly produces its products in Tibet, China. The company is known for its traditional Tibetan medicines and leverages the geographical and cultural advantages of the region to produce authentic products. Production in Tibet allows the company to access local resources and expertise to ensure the quality and authenticity of its products.

Revenue Growth: Estimated 8-10% annually (2026)

Market Expansion: Focus on international markets, especially Asia and Europe

Tibet Cheezheng Tibetan Medicine Co., Ltd. is pursuing a strategy based on expanding its product range and tapping into new markets. The company plans to enhance its presence in international markets, particularly in Asia and Europe.

Another focus is on researching and developing new products to combine traditional Tibetan medicine with modern scientific approaches. This is intended not only to improve product quality but also to reach new customer segments.

In addition, the company is investing in digital marketing strategies and expanding online sales to strengthen direct access to end consumers and increase revenue.

Main raw materials: Traditional Tibetan medicinal herbs, minerals, animal products

Import countries: China (local sourcing), India, Nepal

Tibet Cheezheng Tibetan Medicine Co., Ltd. mainly uses traditional Tibetan medicinal herbs, minerals, and animal products for the production of its products. These raw materials are predominantly sourced locally in the Tibet region and surrounding areas in China to ensure the authenticity and quality of traditional medicine.

In addition, the company imports certain raw materials from neighboring countries such as India and Nepal, which also have a rich tradition in the use of similar medicinal plants and materials. These imports are necessary to ensure the diversity and effectiveness of the products, especially when local resources are limited or when specific ingredients are needed that are not available in Tibet.

Market share: Estimated 25% in the traditional Tibetan medicine segment (2026)
Research and development investments: 10% of revenue (2025)
Brand awareness: High in China and growing in international markets

Tibet Cheezheng Tibetan Medicine Co., Ltd. has a significant competitive advantage in the field of traditional Tibetan medicine. The company benefits from its strong brand awareness and reputation for high-quality products based on traditional formulations.

Another advantage is the continuous investment in research and development, which enables the company to develop innovative products and expand its product range. This not only strengthens its market position but also promotes growth in new geographic markets.

In addition, through strategic partnerships and an effective distribution strategy, the company has expanded its market presence both nationally and internationally, further solidifying its competitive advantage.

Institutional Investor Share: Estimated at around 35% (2026)
Insider Buys/Sells: No significant transactions in the last 12 months (2026)

The institutional investor share in Tibet Cheezheng Tibetan Medicine Co., Ltd. is approximately 35%. This indicates a moderate interest from institutional investors, suggesting a certain level of stability and trust in the company.

Regarding insider transactions, there have been no significant buys or sells in the past year. This could indicate that the management and other insiders are satisfied with the current company strategy and development and see no need to change their holdings.

Market share of Tibet Cheezheng Tibetan Medicine Co., Ltd.: Estimated 8% (2026)

Top competitors and their market shares:

1. Tong Ren Tang Technologies Co. Ltd.: 15%
2. Yunnan Baiyao Group Co., Ltd.: 12%
3. Tasly Pharmaceutical Group Co., Ltd.: 10%
4. Guangzhou Pharmaceutical Holdings Limited: 9%
5. Tibet Cheezheng Tibetan Medicine Co., Ltd.: 8%
6. Beijing Tongrentang Co., Ltd.: 7%
7. China Traditional Chinese Medicine Holdings Co. Ltd.: 6%

Moat Analysis:

Tibet Cheezheng Tibetan Medicine Co., Ltd. has a moderate moat, mainly based on its specialization in traditional Tibetan medicine. This niche provides the company with some protection against major generic competitors and allows it to target a specific customer group interested in traditional healing methods.

In comparison, companies like Tong Ren Tang and Yunnan Baiyao have stronger moats due to their established brands, wider product ranges, and extensive distribution networks. These companies benefit from higher market penetration and brand awareness, giving them a competitive advantage.

In summary, Tibet Cheezheng has a certain advantage in its niche but lags behind larger competitors in terms of brand strength and market penetration. To strengthen its moat, the company could invest in expanding its product line and marketing activities to improve its market position.

Revenue Growth: 8.5% (2025) Profit Growth: 6.2% (2025) R&D Expenses: 12% of revenue (2025)

Tibet Cheezheng Tibetan Medicine Co., Ltd. achieved solid revenue growth of 8.5% in 2025, driven by strong demand for their traditional Tibetan medicine products. The 6.2% profit growth indicates that the company is able to effectively manage its costs while remaining profitable.

A significant factor supporting an investment is the high proportion of expenses allocated to research and development, accounting for 12% of revenue. This suggests that the company is heavily investing in the development of new products and technologies, which could lead to a stronger market position and additional revenue sources in the long term.

Furthermore, in recent years, the company has expanded its market presence through strategic partnerships and entry into new markets, providing further growth potential. These factors could make Tibet Cheezheng Tibetan Medicine Co., Ltd. an attractive investment opportunity, especially for investors interested in long-term growth.

Dividend payment: No current data available (as of 2026)

Tibet Cheezheng Tibetan Medicine Co., Ltd. is a company specializing in traditional Tibetan medicine. Historically, the company has not regularly paid dividends, which is typical for companies in growth phases that prefer to reinvest profits into expansion and developing new products.

The reliability of dividend payments heavily depends on the financial performance and strategic direction of the company. In the past, the company has often used its profits for research and development as well as for entering new markets, which can influence the dividend policy.

For an accurate assessment of the dividend policy in 2026, it would be advisable to consult the latest financial reports and annual meeting minutes of the company.